Finally, the corresponding cutoffs for CRLF2-high in real-time quantitative polymerase chain reaction (RQ-PCR) were also determined, thereby providing a basis for the rapid identification of B-ALL patients with a potentially poor prognosis via CRLF2 expression level. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.